Walbrook PR Welcomes GENinCode to AIM
22 July 2021
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it has acted as Financial PR & Investor Relations advisor for the AIM IPO of GENinCode plc (AIM: “GENI”), the cardiovascular disease ("CVD") company focused on predictive genetics for the prevention of cardiovascular disease. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.